Sri Lanka has a tax-funded universal healthcare system and strong public health outcomes. However, the country continues to face growing pressure from an ageing population and rising non-communicable diseases. As a neighbouring healthcare market, Sri Lanka requires steady access to quality medicines across everyday and long-term care. Torque Pharma supports this need through research-led formulation development and WHO-GMP certified manufacturing, helping maintain a dependable supply for the market.
Quality Indian medicines support better access by helping reduce dependence on high-cost alternatives.
Favourable India-Sri Lanka trade relations make pharmaceutical partnerships more practical and reliable.
WHO-GMP certified production helps maintain quality, safety, and consistency across every supplied formulation.
India’s proximity to Sri Lanka allows faster logistics, practical coordination, and better supply continuity.
